Regulatory Guidance Monthly Review - June 2021
June 2021
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
Planning the Way Forward in Neurodegenerative Disease Studies
Clinical trials involving gene therapies for the treatment of Central Nervous System (CNS)...
Regulatory Guidance Monthly Review - May 2021
May 2021
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
Regulatory Guidance Monthly Review - April 2021
April 2021
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - March 2021
March 2021
Each month, Veristat's regulatory team tracks and shares a selection of new...
Harnessing Efficiencies in a Post-COVID World
The COVID-19 pandemic has accelerated the clinical trial community’s quest to streamline its...
Regulatory Guidance Monthly Review - February 2021
February 2021
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - January 2021
January 2021
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - December 2020
December 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Adapting Human Connection in a Virtual World
How We Planned an International Meeting in a Pandemic
Looking back, 2020 has taught us all a few...